Breakdown | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 |
---|---|---|---|---|---|
Income Statement | |||||
Total Revenue | 11.46B | 10.54B | 10.13B | 8.56B | 6.17B |
Gross Profit | 5.46B | 5.05B | 4.84B | 4.21B | 2.96B |
EBITDA | 1.65B | 1.57B | 1.20B | 1.59B | 869.20M |
Net Income | 490.00M | 538.80M | 226.70M | 369.70M | 224.30M |
Balance Sheet | |||||
Total Assets | 9.95B | 8.05B | 8.02B | 7.07B | 5.16B |
Cash, Cash Equivalents and Short-Term Investments | 731.00M | 1.15B | 1.58B | 1.31B | 964.40M |
Total Debt | 3.74B | 2.61B | 2.45B | 2.37B | 2.10B |
Total Liabilities | 6.58B | 5.18B | 5.39B | 4.73B | 3.67B |
Stockholders Equity | 2.92B | 2.46B | 2.12B | 1.93B | 1.24B |
Cash Flow | |||||
Free Cash Flow | 713.00M | 611.30M | 735.00M | 1.02B | 938.30M |
Operating Cash Flow | 1.23B | 1.14B | 1.08B | 1.27B | 1.06B |
Investing Cash Flow | -1.49B | -543.50M | -320.90M | -848.10M | -334.70M |
Financing Cash Flow | -141.00M | -1.01B | -479.20M | -83.60M | -239.70M |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
---|---|---|---|---|---|---|---|
79 Outperform | £4.34B | 9.03 | 18.22% | 111.38% | 8.69% | -9.09% | |
73 Outperform | £2.39B | 15.80 | 84.81% | 347.14% | 3.07% | 1.42% | |
69 Neutral | £2.94B | 10.25 | 15.02% | ― | -6.82% | -37.46% | |
67 Neutral | ¥267.20B | 13.40 | 6.45% | 2.59% | 5.22% | -11.90% | |
61 Neutral | £397.43M | ― | -62.59% | ― | -15.86% | -18.46% | |
55 Neutral | £498.50M | ― | -27.20% | ― | -14.37% | -28.78% | |
48 Neutral | £247.94M | ― | -96.36% | ― | -16.32% | -202.39% |